Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04657523 · ClinicalTrials.gov registry record · NA
Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study
A NA study, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04657523 is a NA study that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 60 participants.
The verdict
NCT04657523, a NA study, has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This clinical study will involve performing a series of medical imaging procedures of the abdomen using both ultrasound and MRI modalities in subjects at risk for or already diagnosed with Nonalcoholic Fatty Liver Disease (NAFLD). The primary objective of this clinical study is to evaluate the clinical feasibility of an investigational ultrasound technique for quantifying liver fat by comparing specific ultrasound-derived biomarkers with the liver fat percentage obtained from MRI Proton Density Fat Fraction (MRI-PDFF) measurements. All subjects enrolled in this study will undergo two investigational abdominal ultrasound examinations using the Philips EPIQ Ultrasound System and one MRI PDFF examination according to the clinical standard of care.
Interventions
- DEVICE Investigational Liver Fat Quantification Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2023-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04657523
The ClinicalTrials.gov registry entry for NCT04657523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Investigational Liver Fat Quantification Software is the first listed.
NCT04657523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04657523 about?
NCT04657523 is a clinical study titled "Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study". This clinical study will involve performing a series of medical imaging procedures of the abdomen using both ultrasound and MRI modalities in subjects at risk for or already diagnosed with Nonalcoholic Fatty Liver Disease (NAFLD). The primary objective of this clinical study is to evaluate the clini...
What is the current status of trial NCT04657523?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-10-30. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT04657523?
The interventions under investigation include: Investigational Liver Fat Quantification Software (DEVICE).
Who is sponsoring clinical trial NCT04657523?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.